Clinical baseline factors predict response to natalizumab: their usefulness in patient selection

BACKGROUND: Optimal patient selection would improve the risk-benefit ratio of natalizumab treatment for relapsing-remitting multiple sclerosis (RR MS). Clinical features of subjects responding to natalizumab have not been univocally recognized. METHODS: Longitudinal data on RR MS patients treated wi...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Päätekijät: Laroni, Alice, Gandoglia, Ilaria, Solaro, Claudio, Ribizzi, Giuseppe, Tassinari, Tiziana, Pizzorno, Matteo, Parodi, Sergio, Baldassarre, Giovanna, Rilla, Maria Teresa, Venturi, Simonetta, Capello, Elisabetta, Sormani, Maria Pia, Uccelli, Antonio, Mancardi, Giovanni Luigi
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: BioMed Central 2014
Aiheet:
Research Article
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC4045962/
https://ncbi.nlm.nih.gov/pubmed/24885703
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1471-2377-14-103
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia